美国急诊科成年患者中肠杆菌科细菌所致复杂性尿路感染的流行病学
Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States.
作者信息
Lodise Thomas P, Chopra Teena, Nathanson Brian H, Sulham Katherine, Rodriguez Mauricio
机构信息
Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York, USA.
School of Medicine and Division of Infectious Diseases, Wayne State University, Detroit, Michigan, USA.
出版信息
Open Forum Infect Dis. 2022 Jun 24;9(7):ofac315. doi: 10.1093/ofid/ofac315. eCollection 2022 Jul.
Abstract
In this multicenter study of adult patients who presented to the emergency department with an Enterobacterales complicated urinary tract infection (cUTI), high rates of resistance and co-resistance to commonly used oral antibiotics (fluoroquinolones, trimethoprim-sulfamethoxazole, nitrofurantoin, and third-generation cephalosporins) were observed.
摘要
在这项针对因肠杆菌科细菌复杂性尿路感染（cUTI）而到急诊科就诊的成年患者的多中心研究中，观察到对常用口服抗生素（氟喹诺酮类、甲氧苄啶 - 磺胺甲恶唑、呋喃妥因和第三代头孢菌素）的耐药率和共同耐药率很高。
相似文献
1
Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States.
Open Forum Infect Dis. 2022 Jun 24;9(7):ofac315. doi: 10.1093/ofid/ofac315. eCollection 2022 Jul.
2
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort study.
BMC Infect Dis. 2021 Feb 8;21(1):159. doi: 10.1186/s12879-021-05842-0.
3
[National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
Urologe A. 2011 Feb;50(2):153-69. doi: 10.1007/s00120-011-2512-z.
4
Diagnosis and treatment of urinary tract infections across age groups.
Am J Obstet Gynecol. 2018 Jul;219(1):40-51. doi: 10.1016/j.ajog.2017.12.231. Epub 2018 Jan 2.
5
Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 - 2020.
Diagn Microbiol Infect Dis. 2022 Aug;103(4):115717. doi: 10.1016/j.diagmicrobio.2022.115717. Epub 2022 Apr 29.
6
Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
Am J Obstet Gynecol. 2021 Sep;225(3):272.e1-272.e11. doi: 10.1016/j.ajog.2021.04.218. Epub 2021 Apr 20.
7
Risk factors and prognosis of complicated urinary tract infections caused by in hospitalized patients: a retrospective multicenter cohort study.
Infect Drug Resist. 2018 Dec 18;11:2571-2581. doi: 10.2147/IDR.S185753. eCollection 2018.
8
Integron detection for prediction of trimethoprim/sulfamethoxazole susceptibility in children with Enterobacterales urinary tract infections.
J Antimicrob Chemother. 2022 Feb 23;77(3):767-770. doi: 10.1093/jac/dkab431.
9
Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020.
Int J Infect Dis. 2022 Jun;119:142-145. doi: 10.1016/j.ijid.2022.03.052. Epub 2022 Mar 30.
10
National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.
Arch Intern Med. 2002 Jan 14;162(1):41-7. doi: 10.1001/archinte.162.1.41.
引用本文的文献
1
A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract Infection.
Infect Dis Ther. 2025 Apr 24. doi: 10.1007/s40121-025-01149-8.
2
Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of from outpatient centers and nursing homes across the United States (2022-2024).
Antimicrob Agents Chemother. 2025 May 7;69(5):e0186724. doi: 10.1128/aac.01867-24. Epub 2025 Apr 3.
3
The respiratory chain of in urine-like conditions: critical roles of NDH-2 and -terminal oxidases.
Front Microbiol. 2024 Nov 6;15:1479714. doi: 10.3389/fmicb.2024.1479714. eCollection 2024.
4
Clinical Risk Scores to Predict Nonsusceptibility to Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Third-Generation Cephalosporin Among Adult Outpatient Episodes of Complicated Urinary Tract Infection.
Open Forum Infect Dis. 2023 Jun 14;10(8):ofad319. doi: 10.1093/ofid/ofad319. eCollection 2023 Aug.
5
Genotypic characteristics of Uropathogenic isolated from complicated urinary tract infection (cUTI) and asymptomatic bacteriuria-a relational analysis.
PeerJ. 2023 Jun 20;11:e15305. doi: 10.7717/peerj.15305. eCollection 2023.
6
Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatients.
JAC Antimicrob Resist. 2023 May 13;5(3):dlad054. doi: 10.1093/jacamr/dlad054. eCollection 2023 Jun.
7
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber Infection Model.
Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0090822. doi: 10.1128/aac.00908-22. Epub 2023 Feb 9.
8
Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020.
JAC Antimicrob Resist. 2022 Nov 30;4(6):dlac122. doi: 10.1093/jacamr/dlac122. eCollection 2022 Dec.
本文引用的文献
1
Hospital admission patterns of adult patients with complicated urinary tract infections who present to the hospital by disease acuity and comorbid conditions: How many admissions are potentially avoidable?
Am J Infect Control. 2021 Dec;49(12):1528-1534. doi: 10.1016/j.ajic.2021.05.013. Epub 2021 May 30.
2
Emergence of Extended-Spectrum β-Lactamase Urinary Tract Infections Among Hospitalized Emergency Department Patients in the United States.
Ann Emerg Med. 2021 Jan;77(1):32-43. doi: 10.1016/j.annemergmed.2020.08.022. Epub 2020 Oct 31.
3
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018.
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.00346-20.
4
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.
N Engl J Med. 2020 Apr 2;382(14):1309-1319. doi: 10.1056/NEJMoa1914433.
5
Corrigendum to: Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection.
Open Forum Infect Dis. 2020 Jan 13;7(1):ofz536. doi: 10.1093/ofid/ofz536. eCollection 2020 Jan.
6
The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017.
PLoS One. 2019 Dec 10;14(12):e0220265. doi: 10.1371/journal.pone.0220265. eCollection 2019.
7
Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.
Infect Control Hosp Epidemiol. 2020 Jan;41(1):1-18. doi: 10.1017/ice.2019.296. Epub 2019 Nov 26.
8
Predicting the Cost of Health Care Services: A Comparison of Case-mix Systems and Comorbidity Indices That Use Administrative Data.
Med Care. 2020 Feb;58(2):114-119. doi: 10.1097/MLR.0000000000001247.
9
Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with , ESBL-producing or not a retrospective cohort study.
Infect Drug Resist. 2019 Jun 13;12:1691-1702. doi: 10.2147/IDR.S209255. eCollection 2019.
10
Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections.
Expert Opin Pharmacother. 2019 Jun;20(8):903-907. doi: 10.1080/14656566.2019.1594774. Epub 2019 Mar 25.
Zotero 插件